- Home
- VCSA vs ANL Comparison
VCSA vs ANL Comparison
Compare VCSA & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCSA
- ANL
- Stock Information
- Founded
- VCSA 2009
- ANL 2004
- Country
- VCSA United States
- ANL Cayman Islands
- Employees
- VCSA N/A
- ANL N/A
- Industry
- VCSA Computer Software: Prepackaged Software
- ANL
- Sector
- VCSA Technology
- ANL
- Exchange
- VCSA Nasdaq
- ANL Nasdaq
- Market Cap
- VCSA 82.3M
- ANL 81.9M
- IPO Year
- VCSA N/A
- ANL 2023
- Fundamental
- Price
- VCSA $5.38
- ANL $2.05
- Analyst Decision
- VCSA Hold
- ANL Strong Buy
- Analyst Count
- VCSA 3
- ANL 2
- Target Price
- VCSA $5.00
- ANL $9.00
- AVG Volume (30 Days)
- VCSA 166.1K
- ANL 6.8K
- Earning Date
- VCSA 03-13-2025
- ANL 04-08-2025
- Dividend Yield
- VCSA N/A
- ANL N/A
- EPS Growth
- VCSA N/A
- ANL N/A
- EPS
- VCSA N/A
- ANL N/A
- Revenue
- VCSA $910,485,000.00
- ANL $5,000,000.00
- Revenue This Year
- VCSA N/A
- ANL N/A
- Revenue Next Year
- VCSA $2.77
- ANL N/A
- P/E Ratio
- VCSA N/A
- ANL N/A
- Revenue Growth
- VCSA N/A
- ANL N/A
- 52 Week Low
- VCSA $2.07
- ANL $1.85
- 52 Week High
- VCSA $8.19
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- VCSA 57.04
- ANL 38.59
- Support Level
- VCSA $5.34
- ANL $2.02
- Resistance Level
- VCSA $5.43
- ANL $2.49
- Average True Range (ATR)
- VCSA 0.14
- ANL 0.14
- MACD
- VCSA -0.00
- ANL -0.02
- Stochastic Oscillator
- VCSA 52.63
- ANL 7.22
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.